For example, for a representative group of patients with infectious diseases, up to €8182 were saved for each patient with CMV treated with interferon, or €43,549/year for HIV patients treated with efavirenz [40] by genotyping IL28 or CYP2B6, respectively. The gene discussed is CYP2B6; the disease is infectious disease.